Stanford University Medical Center

Medications

Study: Cancer drugs might be able to target tuberculosis

An unexpected link between tuberculosis and cancer may lead to new drug treatments for the bacterial disease that kills more than 1.5 million people each year, according to a study led by researchers at Stanford Medicine.

Diseases, Conditions, Syndromes

Study identifies how Epstein-Barr virus triggers multiple sclerosis

Scientists have long suspected—but failed to prove—a link between certain viral infections and the development of multiple sclerosis, a crippling autoimmune disease that affects nearly 1 million Americans. Now, a study ...

Oncology & Cancer

Two antibodies synergize in triple whammy to pediatric cancers

A combination of anti-cancer antibodies produced a powerfully synergistic response in two hard-to-treat pediatric cancers, according to a new study, in mice, led by researchers at the Stanford University School of Medicine.

Diseases, Conditions, Syndromes

Antibodies in blood soon after COVID-19 onset may predict severity

Blood drawn from patients shortly after they were infected with SARS-CoV-2, the virus that causes COVID-19, may indicate who is most likely to land in the hospital, a study led by Stanford Medicine investigators has found.

page 12 from 40